Dermapharm Holding SE reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EUR 235.72 million compared to EUR 215.71 million a year ago. Net income was EUR 37.37 million compared to EUR 36.31 million a year ago. Basic earnings per share from continuing operations was EUR 0.69 compared to EUR 0.67 a year ago.